CHI-KAT8i5 suppresses ESCC tumor growth by inhibiting KAT8-mediated c-Myc stability
Authors:
Open Access
- 7 January 2025
- journal article
- research article
- Published by Elsevier in Cell Reports
- Vol. 44 (1) , 115135
Abstract
No abstract availableKeywords
Funding Information
- Henan Provincial Science and Technology Research Project (221100310100)
- Henan Provincial Science and Technology Research Project (222102310158)
- Innovative Research Group Project of the National Natural Science Foundation of China
- Science and Technology Department of Henan Province
- National Natural Science Foundation of China (82073075)
This publication has 35 references indexed in Scilit:
- MYC as a target for cancer treatmentCancer Treatment Reviews, 2021
- MYST1/KAT8 contributes to tumor progression by activating EGFR signaling in glioblastoma cellsCancer Medicine, 2019
- Identification of novel inhibitors of histone acetyltransferase hMOF through high throughput screeningEuropean Journal of Medicinal Chemistry, 2018
- BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination DeficiencyCancer Cell, 2018
- Enzyme kinetics and inhibition of histone acetyltransferase KAT8European Journal of Medicinal Chemistry, 2015
- Interplay between the Cancer Genome and EpigenomeCell, 2013
- Cancer Epigenetics: From Mechanism to TherapyCell, 2012
- 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding siteEuropean Journal of Medicinal Chemistry, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- MYST-family histone acetyltransferases: beyond chromatinCellular and Molecular Life Sciences, 2010